Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference

2/19/25 8:00:00 AM ET

Medical/Dental Instruments

Health Care

Get the next $BSX alert in real time by email

MARLBOROUGH, Mass., Feb. 19, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) will participate in TD Cowen's 45^th Annual Health Care Conference on Tuesday, March 4, 2025.

Dan Brennan, executive vice president and chief financial officer, Art Butcher, executive vice president and group president, MedSurg and Asia Pacific, and Kenneth Stein, M.D., senior vice president and chief medical officer, will participate in a 30-minute fireside chat with the host analyst at approximately 9:10 a.m. ET. A live webcast and replay of the session will be accessible at htts://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.

About Boston Scientific

Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X, formerly Twitter.

CONTACTS:

Chanel Hastings

Media Relations

+1 (508) 382-0288

[email protected]

Jon Monson

Investor Relations

+1 (508) 683-5450

[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-td-cowens-45th-annual-health-care-conference-302378128.html

SOURCE Boston Scientific Corporation

Get the next $BSX alert in real time by email

Recent Analyst Ratings for

$BSX

Date	Price Target	Rating	Analyst
6/16/2025	$118.00	Outperform	Leerink Partners
4/16/2025	$113.00	Hold → Buy	Needham
1/10/2025	$108.00	Hold → Buy	Deutsche Bank
10/18/2024		Buy → Hold	Needham
5/30/2024	$90.00	Buy	Goldman
2/1/2024	$65.00 → $80.00	Neutral → Buy	Mizuho
7/19/2023	$59.00	Outperform	Robert W. Baird
6/30/2023	$64.00	Buy	CL King

More analyst ratings

Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference

Chat with this insight

Recent Analyst Ratings for
$BSX

$BSX
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

EVP & Group Pres, Cardiology Fitzgerald Joseph Michael exercised 56,372 shares at a strike of $26.15 and sold $5,799,630 worth of shares (56,372 units at $102.88) (SEC Form 4)

Chairman, President & CEO Mahoney Michael F exercised 105,619 shares at a strike of $20.67 and sold $17,051,136 worth of shares (164,443 units at $103.69), decreasing direct ownership by 4% to 1,476,882 units (SEC Form 4)

Director Ludwig Edward J sold $418,368 worth of shares (4,000 units at $104.59), decreasing direct ownership by 15% to 22,479 units (SEC Form 4)

Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference

Chat with this insight

Recent Analyst Ratings for $BSX

$BSX Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

EVP & Group Pres, Cardiology Fitzgerald Joseph Michael exercised 56,372 shares at a strike of $26.15 and sold $5,799,630 worth of shares (56,372 units at $102.88) (SEC Form 4)

Chairman, President & CEO Mahoney Michael F exercised 105,619 shares at a strike of $20.67 and sold $17,051,136 worth of shares (164,443 units at $103.69), decreasing direct ownership by 4% to 1,476,882 units (SEC Form 4)

Director Ludwig Edward J sold $418,368 worth of shares (4,000 units at $104.59), decreasing direct ownership by 15% to 22,479 units (SEC Form 4)

Recent Analyst Ratings for
$BSX

$BSX
Insider Trading